Galvin, Gaustad & Stein, LLC Laboratory Corp Of America Holdings Transaction History

Galvin, Gaustad & Stein, LLC

  • $1.06 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$209.01 - $232.56 $688,478 - $766,052
-3,294 Reduced 3.39%
93,885 $20.5 Million
Q4 2023

Jan 11, 2024
SELL
$197.69 - $227.29 $149,453 - $171,831
-756 Reduced 0.77%
97,179 $22.1 Million
Q3 2023

Oct 18, 2023
BUY
$201.05 - $221.7 $19.7 Million - $21.7 Million
97,935 New
97,935 $19.7 Million

Others Institutions Holding LH

# of Institutions
95
Shares Held
1.94M
Call Options Held
0
Put Options Held
0
View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

LH Quotes by TradingView
  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Galvin, Gaustad & Stein, LLC Portfolio

Follow Galvin, Gaustad & Stein, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email